mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer

<table>Targeted therapies for head and neck cancer. EGFR: epidermal growth factor receptor; HER-2: human epidermal growth factor receptor 2; VEGFR: vascular endothelial growth factor receptor; IGF-1R: insulin growth factor-1 receptor; mTOR: mammalian target of rapamycin; NF-<i>κ</i>B: nuclear factor-kappa B.</table>

International Scholarly Research Notices

fig1

Figure 1

Figure 1: mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer 